![](/img/cover-not-exists.png)
Development of a zero-order sustained-release tablet containing mesalazine and budesonide intended to treat the distal gastrointestinal tract in inflammatory bowel disease
Gareb, Bahez, Eissens, Anko C, Kosterink, Jos GW, Frijlink, Hendrik WLanguage:
english
Journal:
European Journal of Pharmaceutics and Biopharmaceutics
DOI:
10.1016/j.ejpb.2016.03.018
Date:
March, 2016
File:
PDF, 610 KB
english, 2016